Related Experiment Videos
[Small cell carcinoma of the prostate. Apropos of a case]
I Zrara1, A al Bouzidi, M Rimani
1Service d'Anatomie-Pathologique, Hôpital Militaire d'Instruction Mohammed V Rabat, Maroc.
Journal D'Urologie
|January 1, 1996
Abstract:
Small cell carcinomas of the prostate are rare. These tumors exhibit morphologic and functional neuro-endocrine characteristics. They are a highly aggressive. New therapeutic protocols are being developed in order to be effective against these tumors, particularly those unresponsive to hormonotherapy.
Insights
Rare prostate small cell carcinomas are aggressive neuroendocrine tumors. New treatments are being developed for hormonotherapy-resistant cases.
Area of Science:
- Oncology
- Urologic Oncology
Background:
- Small cell carcinoma of the prostate (SCPC) is a rare and aggressive tumor.
- SCPC exhibits neuroendocrine differentiation, distinguishing it from more common prostate adenocarcinomas.